BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38821186)

  • 1. Characterization of bronchoalveolar lavage fluid microbiota in acute exacerbations of bronchiectasis with non-tuberculous mycobacterial detection.
    Xu Q; Mei Z; Zha Q; Chen J; Qin H; Liu B; Jie Z; Wu X
    Int J Infect Dis; 2024 May; 146():107120. PubMed ID: 38821186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Non-Tuberculous Mycobacterial Pulmonary Disease by Metagenomic Next-Generation Sequencing on Bronchoalveolar Lavage Fluid.
    Zhang X; Chen H; Lin Y; Yang M; Zhao H; Hu J; Han D
    Infect Drug Resist; 2023; 16():4137-4145. PubMed ID: 37396070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the airway microbiome in patients with bronchiectasis.
    Lu D; Li C; Zhong Z; Abudouaini M; Amar A; Wu H; Wei X
    Medicine (Baltimore); 2023 Dec; 102(50):e36519. PubMed ID: 38115299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of gene chip detection of bronchoalveolar lavage fluid in the diagnosis of nontuberculous mycobacterial lung disease.
    Huang M; Lin Y; Chen X; Wu D
    Ann Palliat Med; 2021 Jun; 10(6):6438-6445. PubMed ID: 34154354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Clinical Characteristics and Microbiota in Bronchiectasis Patients Based on Metagenomic Next-Generation Sequencing Technology.
    Shen D; Lv X; Zhang H; Fei C; Feng J; Zhou J; Cao L; Ying Y; Li N; Ma X
    Pol J Microbiol; 2024 Mar; 73(1):59-68. PubMed ID: 38437464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals.
    Wang J; Xu H; Wang X; Lan J
    Front Cell Infect Microbiol; 2022; 12():1083497. PubMed ID: 36760234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.
    Miao XY; Ji XB; Lu HW; Yang JW; Xu JF
    Chin Med J (Engl); 2015 Oct; 128(20):2792-7. PubMed ID: 26481748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Clinical Implications of Nontuberculous Mycobacteria Isolation and Infection among Patients with Bronchiectasis in the Jerusalem Area.
    Kuint R; Azmanov H; Shalom A; Berkman N
    Isr Med Assoc J; 2024 Mar; 26(3):180-185. PubMed ID: 38493330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.
    Mirsaeidi M; Hadid W; Ericsoussi B; Rodgers D; Sadikot RT
    Int J Infect Dis; 2013 Nov; 17(11):e1000-4. PubMed ID: 23683809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
    Aksamit TR; Locantore N; Addrizzo-Harris D; Ali J; Barker A; Basavaraj A; Behrman M; Brunton AE; Chalmers S; Choate R; Dean NC; DiMango A; Fraulino D; Johnson MM; Lapinel NC; Maselli DJ; McShane PJ; Metersky ML; Miller BE; Naureckas ET; O'Donnell AE; Olivier KN; Prusinowski E; Restrepo MI; Richards CJ; Rhyne G; Schmid A; Solomon GM; Tal-Singer R; Thomashow B; Tino G; Tsui K; Varghese SA; Warren HE; Winthrop K; Zha BS
    Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38668710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai].
    Zheng XB; He YF; Wang L; Sun Q; Shen XN; Wu XC; Yang JH; Yao L; Cui HY; Xu B; Yu FY; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):380-387. PubMed ID: 36990702
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis.
    Faverio P; Stainer A; Bonaiti G; Zucchetti SC; Simonetta E; Lapadula G; Marruchella A; Gori A; Blasi F; Codecasa L; Pesci A; Chalmers JD; Loebinger MR; Aliberti S
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing.
    Liu Q; Du J; An H; Li X; Guo D; Li J; Gong W; Liang J
    Front Cell Infect Microbiol; 2023; 13():1205225. PubMed ID: 37424783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan.
    Lin CY; Huang HY; Hsieh MH; Fang YF; Lo YL; Lin SM; Huang YT; Yeh CH; Wang CH; Lin HC
    Front Microbiol; 2022; 13():868435. PubMed ID: 35509319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease.
    Xu P; Yang K; Yang L; Wang Z; Jin F; Wang Y; Feng J
    Front Microbiol; 2022; 13():898195. PubMed ID: 35847073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant nontuberculous mycobacteria and
    Hsieh MH; Lin CY; Wang CY; Fang YF; Lo YL; Lin SM; Lin HC
    Infect Drug Resist; 2018; 11():1137-1143. PubMed ID: 30127630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study.
    Fujita K; Ito Y; Yamamoto Y; Kanai O; Imakita T; Oi I; Ito T; Saito Z; Mio T
    BMC Pulm Med; 2022 Nov; 22(1):395. PubMed ID: 36329435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower airway microbiota in patients with clinically suspected
    Iwasaki K; Matsuzawa Y; Wakabayashi H; Shioya M; Hayakawa S; Tatsuno I
    Heliyon; 2021 Jun; 7(6):e07283. PubMed ID: 34179537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.